-
1
-
-
48749100385
-
Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review
-
10.1093/eurheartj/ehn220 18523058
-
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Eur Heart J 2008 29 1807 1818 10.1093/eurheartj/ehn220 18523058
-
(2008)
Eur Heart J
, vol.29
, pp. 1807-1818
-
-
Martin-Rendon, E.1
Brunskill, S.J.2
Hyde, C.J.3
Stanworth, S.J.4
Mathur, A.5
Watt, S.M.6
-
2
-
-
80051748850
-
+ cell therapy for refractory angina
-
10.1161/CIRCRESAHA.111.245993 21737787
-
+ cell therapy for refractory angina. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA, Circ Res 2011 109 428 436 10.1161/CIRCRESAHA.111.245993 21737787
-
(2011)
Circ Res
, vol.109
, pp. 428-436
-
-
Losordo, D.W.1
Henry, T.D.2
Davidson, C.3
Sup Lee, J.4
Costa, M.A.5
Bass, T.6
Mendelsohn, F.7
Fortuin, F.D.8
Pepine, C.J.9
Traverse, J.H.10
Amrani, D.11
Ewenstein, B.M.12
Riedel, N.13
Story, K.14
Barker, K.15
Povsic, T.J.16
Harrington, R.A.17
Schatz, R.A.18
-
3
-
-
34347402502
-
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial
-
DOI 10.1161/CIRCULATIONAHA.106.687376
-
+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD, Circulation 2007 115 3165 3172 10.1161/CIRCULATIONAHA.106.687376 17562958 (Pubitemid 47018140)
-
(2007)
Circulation
, vol.115
, Issue.25
, pp. 3165-3172
-
-
Losordo, D.W.1
Schatz, R.A.2
White, C.J.3
Udelson, J.E.4
Veereshwarayya, V.5
Durgin, M.6
Poh, K.K.7
Weinstein, R.8
Kearney, M.9
Chaudhry, M.10
Burg, A.11
Eaton, L.12
Heyd, L.13
Thorne, T.14
Shturman, L.15
Hoffmeister, P.16
Story, K.17
Zak, V.18
Dowling, D.19
Traverse, J.H.20
Olson, R.E.21
Flanagan, J.22
Sodano, D.23
Murayama, T.24
Kawamoto, A.25
Kusano, K.F.26
Wollins, J.27
Welt, F.28
Shah, P.29
Soukas, P.30
Asahara, T.31
Henry, T.D.32
more..
-
4
-
-
66349122042
-
Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: A population-based study in Olmsted County, Minnesota
-
10.1097/MCA.0b013e3283239819 19225399
-
Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota. Kiernan TJ, Boilson BA, Sandhu GS, Lennon RJ, Roger VL, Barsness GW, Lerman A, Rihal CS, Simari RD, Coron Artery Dis 2009 20 106 111 10.1097/MCA. 0b013e3283239819 19225399
-
(2009)
Coron Artery Dis
, vol.20
, pp. 106-111
-
-
Kiernan, T.J.1
Boilson, B.A.2
Sandhu, G.S.3
Lennon, R.J.4
Roger, V.L.5
Barsness, G.W.6
Lerman, A.7
Rihal, C.S.8
Simari, R.D.9
-
5
-
-
37249084757
-
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)
-
DOI 10.1093/eurheartj/ehm485
-
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, Thomas P, Bastian B, Chan JK, Lo G, Ho CL, Chan WS, Kwong RY, Parker A, Hauser TH, Chan J, Fong DY, Lau CP, Eur Heart J 2007 28 2998 3005 10.1093/eurheartj/ehm485 17984132 (Pubitemid 350262782)
-
(2007)
European Heart Journal
, vol.28
, Issue.24
, pp. 2998-3005
-
-
Tse, H.-F.1
Thambar, S.2
Kwong, Y.-L.3
Rowlings, P.4
Bellamy, G.5
McCrohon, J.6
Thomas, P.7
Bastian, B.8
Chan, J.K.F.9
Lo, G.10
Ho, C.-L.11
Chan, W.-S.12
Kwong, R.Y.13
Parker, A.14
Hauser, T.H.15
Chan, J.16
Fong, D.Y.T.17
Lau, C.-P.18
-
6
-
-
65649129319
-
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: A randomized controlled trial
-
10.1001/jama.2009.685 19454638
-
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE, JAMA 2009 301 1997 2004 10.1001/jama.2009.685 19454638
-
(2009)
JAMA
, vol.301
, pp. 1997-2004
-
-
Van Ramshorst, J.1
Bax, J.J.2
Beeres, S.L.3
Dibbets-Schneider, P.4
Roes, S.D.5
Stokkel, M.P.6
De Roos, A.7
Fibbe, W.E.8
Zwaginga, J.J.9
Boersma, E.10
Schalij, M.J.11
Atsma, D.E.12
-
7
-
-
33748910402
-
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction
-
DOI 10.1056/NEJMoa060186
-
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, N Engl J Med 2006 355 1210 1221 10.1056/NEJMoa060186 16990384 (Pubitemid 44427445)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.12
, pp. 1210-1221
-
-
Schachinger, V.1
Erbs, S.2
Elsasser, A.3
Haberbosch, W.4
Hambrecht, R.5
Holschermann, H.6
Yu, J.7
Corti, R.8
Mathey, D.G.9
Hamm, C.W.10
Suselbeck, T.11
Assmus, B.12
Tonn, T.13
Dimmeler, S.14
Zeiher, A.M.15
-
8
-
-
79956368558
-
Resident vascular progenitor cells - Diverse origins, phenotype, and function
-
10.1007/s12265-010-9248-9 21116882
-
Resident vascular progenitor cells-diverse origins, phenotype, and function. Psaltis PJ, Harbuzariu A, Delacroix S, Holroyd EW, Simari RD, J Cardiovasc Transl Res 2011 4 161 176 10.1007/s12265-010-9248-9 21116882
-
(2011)
J Cardiovasc Transl Res
, vol.4
, pp. 161-176
-
-
Psaltis, P.J.1
Harbuzariu, A.2
Delacroix, S.3
Holroyd, E.W.4
Simari, R.D.5
-
9
-
-
33750991077
-
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells
-
DOI 10.1161/CIRCULATIONAHA.106.644518, PII 0000301720061114000014
-
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW, Circulation 2006 114 2163 2169 10.1161/CIRCULATIONAHA.106.644518 17075009 (Pubitemid 44747897)
-
(2006)
Circulation
, vol.114
, Issue.20
, pp. 2163-2169
-
-
Kawamoto, A.1
Iwasaki, H.2
Kusano, K.3
Murayama, T.4
Oyamada, A.5
Silver, M.6
Hulbert, C.7
Gavin, M.8
Hanley, A.9
Ma, H.10
Kearney, M.11
Zak, V.12
Asahara, T.13
Losordo, D.W.14
-
10
-
-
70349785585
-
Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction
-
19752372
-
Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH, Martens TP, Itescu S, Schuster MD, Plappert T, St John-Sutton MG, Spinale FG, Circulation 2009 120 Suppl 11 220 S229 19752372
-
(2009)
Circulation
, vol.120
, Issue.SUPPL. 11
-
-
Dixon, J.A.1
Gorman, R.C.2
Stroud, R.E.3
Bouges, S.4
Hirotsugu, H.5
Gorman, J.H.6
Martens, T.P.7
Itescu, S.8
Schuster, M.D.9
Plappert, T.10
St John-Sutton, M.G.11
Spinale, F.G.12
|